Aptorum Group Limited

NasdaqCM:APM

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

💉 Vaccines

Location

United Kingdom

Market Cap

USD 9.93 M

Share Price

USD 1.39

Avg Daily Volume

3,344,853

Change (1 day)

-4.79%

Change (1 year)

-56.01%

Change (YTD)

86.45%

Aptorum Group Limited EBITDA for the year ending December 31, 2023: USD -9.22 M

Aptorum Group Limited EBITDA is USD -9.22 M for the year ending December 31, 2023, a -40.94% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Aptorum Group Limited EBITDA for the year ending December 31, 2022 was USD -15.62 M, a -13.31% change year over year.
Aptorum Group Limited EBITDA for the year ending December 31, 2021 was USD -18.02 M, a -377.24% change year over year.
Aptorum Group Limited EBITDA for the year ending December 31, 2020 was USD 6.50 M, a -142.98% change year over year.
Aptorum Group Limited EBITDA for the year ending December 31, 2019 was USD -15.12 M, a 51.27% change year over year.